ArmeoSenso - Home Therapy and Assessment for Patients With Arm Impairments Based on Wearable Movement Sensors

N/ACompletedNCT02098135

University of Zurich14 enrolled

Overview

stroke, spinal cord injury, rehabilitation, home therapy, upper limb, arm, virtual reality, interia sensor, * Trial with medical device

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Stroke Spinal Cord Injury

Interventions

ArmeoSensoDEVICE

Virtual realty therapy with a touchscreen computer and movement sensors, over 42 days.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * 18 years old * Stroke or spinal cord injury in prehistory * Motor deficits of the upper limb (s) * Lifting the paretic arm against gravity possible AND * Minimum amount of movement in the horizontal plane of 20 x 20 cm * Ability and willingness to participate in the study Exclusion criteria: * Severe aphasia * Severe dementia * Severe depression * Relevant restriction of vision, which can not be compensated by aids (eg hemianopia)

Locations (1)

University Hospital Zurich, Divison of Neurology

Zurich, Canton of Zurich, Switzerland

Outcomes

Primary Outcomes

Numbers of participant which can perform the ArmeoSenso - training.

Time frame: 42 days

Secondary Outcomes

Improvement in the Arm function

WMFT (Wolf Motor Function Test), FMA-UL (Fugl-Meyer Assessment - Upper Limb), GRASSP (Graded and Redefined Assessment of Strength, Sensibility and Prehension)

Time frame: 42 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.